[ST:NB] W02 - Neurotransmitters
contents
- neurotransmitter synthesis
- neurotransmitter release
- clostridial toxins - botox
- signal termination
- receptors
- disconnect
- reference
- action potentials transmit a message from one end of a cell (neuron) to the other
- messages need to be transmitted between cells across the synapse
- an analogy would be:
- breathing in air before talking: action potential
- making the sounds to communicate: neurotransmitters
- neurons talk to each other using the language of neurotransmitters
- neurotransmitters are a list of molecules
- neurotransmitters have several functions in the body
- one of their dedicated functions is inter-neuron communication
- neurotransmitters are made in the nervous system and are released from synaptic terminals
neurotransmitter synthesis

fig: neuron anatomy
- cell organelles include:
- nucleus: has the DNA
- mitochondria: powerhouse of the cell
- endoplasmic reticulum: cell protein manufacturing centers
- endosomes and lysosomes: garbage collectors of the cell
- axon: leads to the synaptic terminal
synaptic terminal
- the synaptic terminal has synaptic vesicles
- these are organelles with a vesicular membrane
- inside a membrane sit neurotransmitter molecules

fig: synaptic terminal anatomy
neurotransmitter molecules
- neurotransmitters may be any of the following molecules
- acetylcholine
- glutamate
- GABA (gamma-aminobutyric acid)
- glycine
- dopamine
- norepinephrine
- epinephrine
- histamine
- serotonin
- ATP (adenosine tri-phosphate)
- enkephalin
- beta-endorphin
- dynorphin
- vasopressin
- oxytocin
- insulin
- galanin
- nitric oxide
- substance P
- calcitonin gene-related protein (CGRP)
- bombesin
- kisspeptin
- 100+ more
- synthesis of neurotransmitters may be used as a therapeutic tool
- eg. in parkinson’s disease, dopamine making cell groups die
- substrate subjected to a series of enzymatic reactions generate neurotransmitters
- to treat parkinson’s disease, the substrate in drugs sinemet (aka parcopa) is used
- dopamine is synthesized in patient’s system when flooded with said substrate
- neurotransmitters are packaged in vesicles
- these packages are neural communication units
neurotransmitter release
- the cell has a lot of membranes
- all the cell organelles have membranes
- other vesicles traffic through the membranes to their target locations
- the fusion between the membranes of vesicle and the target organelle membrane happens all the time to enable this traffic
- however, neuron vesicles should not fuse with the neuron cell membrane all the time
- neuron vesicle fusion should occur only in the event of an action potential
- if it took place all the time, neuron communication and hence bodily regulation would fail
key to neurotransmitter release
- suppress constitutive (always active) release
- at the synaptic terminal
- link release to action potential
release process
- action potential travels down the axon
- neurotransmitters packaged in vesicles are held ready in the synapse
- when the action potential occurs, the potential across the cell membrane skyrockets
- this begins opening up ion channels
- this lets in \(Ca^{++}\) ions into the synaptic terminal through the opened ion channels
- the influx of calcium ions triggers the neurotransmitter release
- by enabling the fusion of vesicle and neuron cell membrane fusion
release trigger
- vesicles of neurotransmitters are released only when \(Ca^{++}\) ions flood the synaptic terminal
- this occurs only when the ions channels are opened in the neuron cell membrane by its own action potential event

fig: cell membrane and vesicle membrane fusion
- in the presence of \(Ca^{++}\), the vesicle membrane fuses with the neuron cell membrane internally to open up the inner neurotransmitter molecules into the synaptic gap

fig: vesicle membrane patches the hole in the cell membrane
- then the vesicle membrane closes the hole created in the cell membrane to release the molecules, after the release
- so, the act of releasing the neurotransmitters is not pumping it out to the target
- the molecules are simply ejected out of the neuron body
- the hole created in the neuron membrane is then closed with the vesicle membrane that held the neurotransmitters packed together to begin with
clostridial toxins - botox
- botox is one of the several clostridial toxins made by the clostridial bacteria
- botox stands for botulinum toxin
snare complex
- three proteins hold vesicles close to the cell membrane
- one is anchored in the vesicle membrane
- other two anchored in the cell membrane
- these are also called pin proteins
- when \(Ca^{++}\) ions enters the synaptic terminal
- it forces shape change of the snare complex
- this forces the vesicle membrane into the cell membrane
- makes the fusion of the vesicle with cell membrane inevitable
botox action
- clostridial toxin cuts the proteins of the snare molecules
- this prevents neurotransmitter release
- particular case
- prevents release of neurotransmitter from motor-neurons
malicious use
- release from motor neuron to diaphragm is an area of concern
- for a patient administered with a sufficient amount of botox
- diaphragm is a muscle that facilitates breathing
- botox (a bio-toxin) may be used as a weapon (of mass destruction) to clog human diaphragms
- the dosage matters
therapeutic use
- focal dystonia:
- there is a continual contraction of a muscle stemming from a basal ganglia disorder
- botox, in low and very local dosage, is injected to treat focal dystonia
- it blocks the disorder enforced contraction of the muscle
- cosmetic applications:
- botox prevents motor neuron from releasing neurotransmitter to muscles
- this prevents wrinkle generation
signal termination
- release happens to get a message across the synaptic cleft
- from pre-synaptic cell (the synaptic terminal releasing the neurotransmitter)
- to post-synaptic cell
- synaptic cleft is a short distance separation between the communicating cells
- molecules released into the synaptic cleft are about to be received
- the message needs to be terminated
- there three different mechanisms for message termination
diffusion
- the post-synaptic cell is sensitive with receptors for released molecules only in a certain area
- this means that diffusion is a natural process that ends the communication
- as the released molecules diffuse out of the receiving cell’s sensitive area
re-uptake
- transporters of the pre-synaptic cell take un-communicated neurotransmitters in the synaptic cleft back in
- neurons recycle neurotransmitters
- the neurotransmitters taken back in are repackaged in vesicles
- released again at action potentials
- re-uptake is crucial for drugs like serotonin and dopamine to work
- as a result, re-uptake mechanism may be used treat depression
- re-uptake may also engage circuits that lead to drug abuse
degradation
-
enzymes in the synaptic cleft eat up the leftover neurotransmitters
- eg: acetylcholine neurotransmitter is eaten up by AChE (acetylcholinesterase)
- acetylcholine is used by motor neurons
- myasthenia gravis:
- not enough acetylcholine is released, or receptors for it are less
- in this case, action of AChE (acetylcholinesterase) is inhibited
- to prevent acetylcholinesterase from eaten up the existing acetylcholine
- pesticides such as ceron are based on blocking the AChE
- acetylcholine is not eaten up by AChE
- this leaves to much acetylcholine for the post-synaptic cell
- too much acetylcholine in a post-synaptic motor neuron make it actuate the muscle to stay contracted continuously
- in case this is the diaphragm, it leads to death
- because the diaphragm stays locked
receptors
- the post-synaptic cell has to receive the message
- receptors populate the post-synaptic cell membrane
- receptors are multi-protein complexes
- as the neurotransmitter molecules make their way across the cleft
- the surviving molecules reach the receptors
structure
- post-synaptic membrane has actual pores
- normally they are closed
- ion can go in and out of the membrane through these pores
- \(K^+\) travels out of the cell
- \(Na^+\) and \(Cl^-\) travel into the cell
- when receptors bind to the receptors
- pores become available for the ions to travel along
- ionotropic receptors: open ion channels (open pores)
- pore opens in \( < ms \)
- direction of travel depends on the receptor
- pores become available for the ions to travel along
- there are about 10 types of ionotropic receptors
- knee jerk reflex type effect
classes of receptors
excitatory receptors
- any receptor that takes the cell membrane voltage higher, closer to \(0V\)
- eg:
- glutamate receptor
- glutamate neurotransmitter binds to this receptor
- makes action potential firing more likely
inhibitory receptor
- any receptor that takes the cell membrane voltage lower than it default \(-65mV\)
- eg:
- GABA receptor
- GABA neurotransmitter binds to this receptor
- makes action potential firing less likely
flow of communication
- the pre-synaptic and the post-synaptic cells action potentials must fire in succession with appropriate overlap
- this enable flow of neurotransmitters from the pre-synaptic to post-synaptic cell
- across the synaptic cleft
- where the neurotransmitter ejected by the pre-synaptic cell collect on the post-synaptic receptors
- this opens pores for ions to enter or exit the post-synaptic cell
disease and therapeutics
-
diseases receptors are lost: myasthenia gravis
- consider human motor-neuron synaptic terminal and muscle interface
- synaptic vesicles contain ACh (acetylcholine neurotransmitter)
- acetylcholine neurotransmitter contracts muscles
- muscle membrane has acetylcholine receptors
- in myasthenia gravis, the immune system antibodies made in the body destroys a whole lot of the acetylcholine receptors of the muscle cells
- to counter this condition, the inhibitor (acetylcholinesterase) that eats away acetylcholine in the synaptic cleft is blocked
- so, more acetylcholine floods the cleft, as it is kept around longer and not degraded by its inhibitor
- the probability of it binding with a receptor increases
- this situation is better than having a low receptor count and low concentration of acetylcholine
- another counter is to suppress the immune system nad its antibodies from destroying the acetylcholine receptors
metabotropic receptors
- they bind neurotransmitters, but do not directly lead to an electric change
- they cannot form a pore
- they activate G protein by attaching with them
- so, they are also called G protein coupled receptors (GPCR)
- activated G protein stimulate enzymatic reactions
- or bind to other molecules which inturn stimulate enzymatic reactions
- the effect of metabotropic receptors take more time than ionotropic receptors
- in the order of \(mS\)
- their effect amplifies
- goes on in many rounds
- their effect is difficult to turn off
- the effect could be to open, close or not affect ion channels at all
- huge variations in effect
- there are more than a 1000 types of metabotropic receptors
-
adrenaline rush type effect
- all autonomic target organs use metabotropic receptors
- drugs used to treat glaucoma, hypertension, motion sickness, asthma, IBS
- all act on GPCRs
- GPCRs are a common target for drug development
most commonly prescribed drug
- in the u.s.a, most commonly prescribed drug is vicodin
- mix of hydrocodone and acetaminophen
- hydrocodone, the active ingredient in vicodin, acts on GPCR called the mu-opiod receptor
disconnect
- consider myelin sheath, a part of neuro-anatomy
- even if we knew everything about how myelin works
- it would not tell us what happens if myelin fails
- it depends on what is affected because of the failure of myelin
- the neurons functions that are affected by myelin failure
- the context in the complex neuro-anatomy system is important to analyze the effects of failure
- for this understanding the system as a whole is crucial